Want to see VCNX full AI Analyst Report?
| Dec 25 | Dec 24 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.10M | $ 601.00K | $ 570.00K | $ 100.00K | $ 900.00K |
| Gross Profit | $ 2.06M | $ 601.00K | $ 570.00K | $ 68.00K | $ 731.00K |
| Operating Income | $ -5.23M | $ -18.73M | $ -22.89M | $ -19.91M | $ -22.49M |
| EBITDA | $ -5.20M | $ -18.54M | $ -19.75M | $ -19.61M | $ -21.40M |
| Net Income | $ -5.26M | $ -18.63M | $ -20.25M | $ -19.72M | $ -22.38M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 140.00K | $ 1.11M | $ 1.53M | $ 6.39M | $ 8.59M |
| Total Assets | $ 1.80M | $ 2.60M | $ 3.63M | $ 7.98M | $ 9.84M |
| Total Debt | $ 5.52M | $ 25.00K | $ 247.00K | $ 485.00K | $ 390.00K |
| Net Debt | $ 5.38M | $ -1.08M | $ -1.29M | $ -5.91M | $ -8.20M |
| Total Liabilities | $ 9.39M | $ 5.08M | $ 5.94M | $ 2.78M | $ 2.43M |
| Stockholders' Equity | $ -7.59M | $ -2.49M | $ -2.31M | $ 5.19M | $ 7.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -6.46M | $ -16.21M | $ -17.30M | $ -19.17M | $ -25.33M |
| Operating Cash Flow | $ -6.45M | $ -16.19M | $ -17.23M | $ -19.07M | $ -25.30M |
| Investing Cash Flow | $ -9.00K | $ -22.00K | $ -67.00K | $ -99.00K | $ -32.00K |
| Financing Cash Flow | $ 5.49M | $ 15.78M | $ 12.45M | $ 16.98M | $ 23.32M |
Vaccinex Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.